The middle cerebral artery (MCA) and its branches are the cerebral vessels most severely affected by ischemic stroke, accounting for approximately 70% of infarctions. Thus, occlusion of this artery most closely resembles focal cerebral ischemia stroke in humans. The most common method of focal ischemic stroke is intraluminal thread occlusion of the MCA, which has been used in more than 40% of stroke research. The endovascular filament MCAO modeling involves surgical filament insertion of the external carotid artery threaded into the internal carotid artery (ICA) until prompted by obstruction of the MCA at the origin, in the cessation of blood flow and subsequent cerebral infarction. The suture is located at the junction between the anterior cerebral artery and the middle cerebral artery and is retained in place for a predetermined period or permanently.
Fig. 1. Illustration of endovascular thrombectomy after acute ischemic stroke. (Sutherland et al., 2016)
Ace Therapeutics is proud to provide customized intraluminal filament model of MCAO to researchers in the stroke field. Ace Therapeutics has a wealth of experience and a dedicated team of scientists that allow us to model permanent or transient MCAO (pMCAO or tMCAO) focal ischemic stroke according to the specific needs of our clients. All studies can be customized and adapted to meet customer needs.
We can construct intraluminal filament model of MCAO in animals. The approximate procedure is as follows:
1) Under the operating microscope, the bifurcation of the right common carotid artery is exposed through a midline incision in the neck.
2) A 4-0 monofilament nylon suture with its tip rounded near a flame is introduced into the right external carotid artery and advanced into the internal carotid artery for a length of 17~20 mm from the bifurcation.
3) These methods place the tip of the suture at the origin of the anterior cerebral artery, thereby occluding the middle cerebral artery. The suture is left in place until death. If removal is followed by suturing at certain time intervals (30 minutes, 1 hour, or 2 hours), reperfusion (transient ischemia) is achieved; if the filament is left in place (24 hours) the procedure is suitable as a model of permanent ischemia.
4) Following MCA occlusion, animals are allowed to awaken from anesthesia. Surgical mortality is <10% in this model.
To assess the severity of cerebral infarction, we can stain brain sections with 2,3,5-triphenyl tetrazolium chloride (TTC) to determine ischemia in brain tissue. We also offer cognitive/behavioral tests to measure spatial memory, contralateral motor function and coordination (stairs, adhesion removal test, water maze, grip test).
At Ace Therapeutics, our endovascular filament model of MCAO provides a more comprehensive approach for your focal cerebral ischemic stroke preclinical research. Need to know more? Contact us and let one of our experts provide you with all the answers you need.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.